C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. 2000

M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
Institute of Chemistry and Technology of Drugs, University of Perugia, Italy.

Buckminsterfullerenols were recently investigated for their protective properties in different models of acute and chronic neurodegeneration. We tested C3-fullero-tris-methanodicarboxylic acid in our in vitro model of apoptotic neuronal death, which consists of shifting the culture K+ concentration from 25 to 5 mM for rat cerebellar granule cells. The impairment of mitochondrial respiratory function as well as chromatin derangement and fragmentation of DNA in apoptotic oligonucleosomes that occur in these conditions were protected by this compound in a concentration-dependent way. To assess whether antioxidant activity could account for the rescue of cerebellar granule cells from apoptosis, we tested the fullerene derivative under FeSO4-induced oxidative stress and found significant protection. Thus, we visualized membrane and cytoplasmic peroxides and reactive oxygen species and found a significant reduction of the species after 24 h in 5 mM K+ with the fullerene derivative. Such evidence suggests that this compound exerts a protective role in cerebellar granule cell apoptosis, likely reducing the oxidative stress.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010545 Peroxides A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed) Peroxide
D011191 Potassium Deficiency A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed) Deficiencies, Potassium,Deficiency, Potassium,Potassium Deficiencies
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002531 Cerebellum The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills. Cerebella,Corpus Cerebelli,Parencephalon,Cerebellums,Parencephalons
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D003998 Dicarboxylic Acids Acyclic acids that contain two carboxyl groups and have the formula HO2C-R-CO2H, where R may be an aromatic or aliphatic group. Acids, Dicarboxylic

Related Publications

M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
January 1998, Neuroscience letters,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
December 1998, Annals of the New York Academy of Sciences,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
February 1999, Journal of neuroscience research,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
August 2001, Naunyn-Schmiedeberg's archives of pharmacology,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
October 2007, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
May 2002, The European journal of neuroscience,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
November 2002, Neurochemical research,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
January 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
November 2002, The Journal of biological chemistry,
M Bisaglia, and B Natalini, and R Pellicciari, and E Straface, and W Malorni, and D Monti, and C Franceschi, and G Schettini
July 1998, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!